HLA-DRA Antikörper (AA 27-216)
Kurzübersicht für HLA-DRA Antikörper (AA 27-216) (ABIN7437542)
Target
Alle HLA-DRA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 27-216
-
Verwendungszweck
- Polyclonal Antibody to HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA)
-
Spezifität
- The antibody is a rabbit polyclonal antibody raised against HLA-DRA. It has been selected for its ability to recognize HLA-DRA in immunohistochemical staining and western blotting.
-
Aufreinigung
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
-
Immunogen
- Recombinant HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA) corresdonding to Lys27~Glu216 with N-terminal His Tag
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Western blotting: 0.01-2 μg/mL,Optimal working dilutions must be determined by end user.
-
Kommentare
-
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 24 months
-
-
- HLA-DRA (HLA Class II DR alpha (HLA-DRA))
-
Andere Bezeichnung
- HLA-DRA
-
Hintergrund
- MHCDRa, HLADRa, Major Histocompatibility Complex Class II DR Alpha
-
UniProt
- P01903
-
Pathways
- T-Zell Rezeptor Signalweg, CXCR4-mediated Signaling Events, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Target
-